VIDEO: Low risk for congestive heart failure exacerbation with Zinplava for C. difficile

CHICAGO — In this Healio video exclusive, Paul Feuerstadt, MD, FACG, AGAF, recaps results from a real-world analysis of Zinplava for prevention of recurrent Clostridioides difficile infection in patients with congestive heart failure.“C. difficile is a major problem in the United States,” Feuerstadt, assistant clinical professor of medicine at Yale University School of Medicine and attending gastroenterologist at PACT Gastroenterology Center, said. “It is estimated about a half a million people will be diagnosed with this infection on an annual basis.“Importantly,Read More